Dooms Christophe, van Baardwijk Angela, Verbeken Eric, van Suylen Robert Jan, Stroobants Sigrid, De Ruysscher Dirk, Vansteenkiste Johan
Department of Pulmonology and Leuven Lung Cancer Group, University Hospitals Leuven, Belgium.
J Thorac Oncol. 2009 Jul;4(7):822-8. doi: 10.1097/JTO.0b013e3181a97df7.
The prognostic value of quantitative 18F-fluoro-2-deoxy-D-glucose (FDG) uptake on positron emission tomography (PET) is controversial in unselected patients with non-small cell lung cancer (NSCLC). We assessed the in vivo FDG uptake, measured as maximum pixel standardized uptake value (SUVmax), in stages I and II NSCLC for its prognostic value and association with in vitro quantitative morphology of tumor vitality.
Prospective FDG-PET data were available in 91 consecutive patients operated for pathologic stages I and II NSCLC. Quantitative morphology was performed of tumor architecture, tumor cell density and immunohistochemical biomarkers for apoptosis (caspase-3), cell proliferation (Ki-67), hypoxia (HIF-1alpha), cellular pH regulation (carbonic anhydrase IX [CAIX]), and microvessel density (CD31).
SUVmax >or= median and SUVmax partial volume corrected for lesion size (PVC SUVmax) >or= median were associated with an increased risk of death in univariable analysis. After correcting for stage, tumor size and age in multivariable analysis, only PVC SUVmax >or= median remained significant. The strong significant association between tumor size and SUVmax weakened after PVC, suggesting that an important amount of SUVmax can be simply explained by tumor size, which is less in case for PVC SUVmax that associates more to the tumor cell density. In multivariable logistic regression analysis, a PVC SUVmax >or= median could be explained by high Ki-67 and high-CAIX length density.
PVC SUVmax has a prognostic value in completely resected stages I and II NSCLC. A high-quantitative FDG uptake is associated with characteristics of tumor vitality such as high tumor cell density, high cell proliferation, and extracellular acidosis.
在未经选择的非小细胞肺癌(NSCLC)患者中,正电子发射断层扫描(PET)上定量18F-氟-2-脱氧-D-葡萄糖(FDG)摄取的预后价值存在争议。我们评估了I期和II期NSCLC患者体内FDG摄取情况,以最大像素标准化摄取值(SUVmax)衡量,探讨其预后价值以及与肿瘤活力体外定量形态学的相关性。
91例连续接受手术治疗的I期和II期NSCLC患者有前瞻性FDG-PET数据。对肿瘤结构、肿瘤细胞密度以及凋亡(半胱天冬酶-3)、细胞增殖(Ki-67)、缺氧(HIF-1α)、细胞pH调节(碳酸酐酶IX [CAIX])和微血管密度(CD31)的免疫组化生物标志物进行定量形态学分析。
在单变量分析中,SUVmax≥中位数以及经病变大小校正的SUVmax部分体积(PVC SUVmax)≥中位数与死亡风险增加相关。在多变量分析中校正分期、肿瘤大小和年龄后,只有PVC SUVmax≥中位数仍具有显著性。PVC后肿瘤大小与SUVmax之间的强显著相关性减弱,这表明SUVmax的重要部分可简单地由肿瘤大小解释,而PVC SUVmax与肿瘤细胞密度的相关性更强,这种情况则较少。在多变量逻辑回归分析中,PVC SUVmax≥中位数可由高Ki-67和高CAIX长度密度解释。
PVC SUVmax在完全切除的I期和II期NSCLC中具有预后价值。高定量FDG摄取与肿瘤活力特征相关,如高肿瘤细胞密度、高细胞增殖和细胞外酸中毒。